N-Acetylcysteine and Liver Transplant. Advantages of its Administration in Multi-Organ Donors Especially During World-Economical-Crisis. Long-Term Sub-Group Analysis in a Randomized Study
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2024.11.038 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Michele Finotti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical, Dallas, Texas; 4th Surgery Unit, Regional Hosp…. Hauptthemen laut MEDLINE: Acetylcysteine, Liver Transplantation, Tissue Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Liver transplantation (LT) is the main indication for the treatment of end-stage liver disease but have to face organ shortages. Using marginal donors is an option to increase the donor pool. Previous studies showed that the graft procured using N-acetylcysteine (NAC) provides a longer survival compared to perfusion with standard solutions, especially in marginal liver donors. We now evaluate the effect of NAC perfusion compared to control (no NAC protocol) at a 5-year follow-up, with a special focus on the overall survival (OS) and graft survival. METHODS: Single-center, retrospective review of the OS and graft survival among NAC and control group, with a sub-stratification based on the LT indication. RESULTS: 140 donors were enrolled: 69 in the NAC protocol and 71 in the control group. The 5-year OS was 84% in the NAC protocol compared to 63% in the control (P = .0045). In LT for HCC, the OS at 5 years was 80% and 55% in the study group and control group, respectively (P = .04), with no statistical difference in the RFS (P = .46). Furthermore, in cost analysis, the resources needed for the NAC protocol is negligible compared to the control group. Beneficial tendency of NAC protocol application has been seen in the other organs (lungs, hearts, pancreas, kidney and intestine) CONCLUSION: The application of NAC infusion in liver donors improves the overall survival of the recipient, especially in the HCC and HCV LT indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical, Dallas, Texas; 4th Surgery Unit, Regional Hospital Treviso, University of Padua, DISCOG, Padua, Italy; Unit of Hepat…
- Unit of Gastroenterology and Multivisceral Transplant, Department of Surgery, Oncology and Gastroenterology University, Hospital of Padua, Padua, Italy.
- Unit of Hepatobiliary Surgery and Liver Transplantation, University Hospital of Padua, Padua, Italy.
- Liver Transplant Service, Salt Lake City, Utah; Liver Center, Primary Children's Hospital, Salt Lake City, Utah.
- Unit of Hepatobiliary Surgery and Liver Transplantation, University Hospital of Padua, Padua, Italy; Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (DiMePRe-J) Bari University; Department of Surgery…
Zitieren
APA
Finotti, M., Zanetto, A., Vitale, A., Rodriguez-Davalos, M., Burra, P., Cillo, U., & D'Amico, F. (2025). N-Acetylcysteine and Liver Transplant. Advantages of its Administration in Multi-Organ Donors Especially During World-Economical-Crisis. Long-Term Sub-Group Analysis in a Randomized Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.11.038
Vancouver
Finotti M, Zanetto A, Vitale A, Rodriguez-Davalos M, Burra P, Cillo U, et al. N-Acetylcysteine and Liver Transplant. Advantages of its Administration in Multi-Organ Donors Especially During World-Economical-Crisis. Long-Term Sub-Group Analysis in a Randomized Study. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2024.11.038
BibTeX
@article{Finotti2025,
author = {Finotti, Michele and Zanetto, Alberto and Vitale, Alessandro and Rodriguez-Davalos, Manuel and Burra, Patrizia and Cillo, Umberto and D'Amico, Francesco},
title = {N-Acetylcysteine and Liver Transplant. Advantages of its Administration in Multi-Organ Donors Especially During World-Economical-Crisis. Long-Term Sub-Group Analysis in a Randomized Study},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2024.11.038}
}
EUVIMED